Nomura Healthcare Fund Class R (DLRHX) - Health fund with $934.76 Million in assets. The fund allocates 41.27% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is Eli Lilly Co at 3.82% of total assets. This is followed by Regeneron Pharmaceuticals Inc (4.01%) and Amgen Inc (3.55%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| Eli Lilly Co | 3.82% | - | - |
| Regeneron Pharmaceuticals Inc | 4.01% | - | - |
| Amgen Inc | 3.55% | - | - |
| UnitedHealth Group Inc | 3.93% | - | - |
| Merck Co Inc | 3.95% | - | - |
| Elevance Health Inc | 3.90% | - | - |
| Pfizer Inc | 4.43% | - | - |
| Boston Scientific Corp | 5.64% | - | - |
| AbbVie Inc | 4.40% | - | - |
| Roche Holding AG | 3.64% | - | - |
| Chugai Pharmaceutical Co Ltd | 3.74% | - | - |
| UCB SA | 5.52% | - | - |
| Gilead Sciences Inc | 3.54% | - | - |
| UCB SA NPV | 5.19% | - | - |
| Regeneron Pharmaceuticals, Inc. COM | 5.46% | - | - |
| Pfizer Inc. COM | 4.84% | - | - |
| Gilead Sciences Inc. COM | 4.40% | - | - |
| AbbVie Inc. COM | 4.09% | - | - |
| Merck Co., Inc COM | 3.89% | - | - |
| AstraZeneca PLC ORD USD0.25 | 3.86% | - | - |
| Chugai Pharmaceutical Co Ltd. NPV | 3.73% | - | - |
| Eli Lilly Co. COM | 3.60% | - | - |
| Roche Holding AG CHF0.001 | 3.30% | - | - |
| ABBVIE INC COM | 4.19% | - | - |
| ELI LILLY COMPANY COM | 4.16% | - | - |
| REGENERON PHARMACEUTICALS INC COM | 3.91% | - | - |
| UNITEDHEALTH GROUP INC COM | 3.88% | - | - |
| PFIZER INC COM | 3.84% | - | - |
| MERCK COMPANY INC COM | 3.68% | - | - |
| GILEAD SCIENCES INC COM | 3.54% | - | - |
| ASTRAZENECA PLC ORD USD0.25 | 3.27% | - | - |
| ELEVANCE HEALTH INC COM | 3.25% | - | - |